Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Blog Post

December 10, 2019

CVS Caremark Targets Pharmacies With New "Aberrant Quantitates and Volume" Contract Amendment

On January 1, 2020, CVS Caremark will begin enforcing a new contractual provision designed to ensure its independent network pharmacies do not dispense more than 25 percent of products that are on Caremark’s “Aberrant Product List” by claims or dollars—as determined solely by Caremark.

The restrictions are intended to curb “dispensing aberrant quantities” or “high volumes” within a therapeutic category. The medications contained on the list are extensive and include numerous common medications. Some of the medications appear to be on the list solely because of their high profit margin for the pharmacy. To enforce the new provision, among other tactics, Caremark will perform monthly monitoring of its network pharmacies. If a pharmacy breaches the “aberrant product” threshold, it will receive a cease-and-desist notice. Additional violations by the pharmacy will subject it to network termination and chargebacks on claims.

The contractual amendment may have a severe impact on your pharmacy business, including your relationships with patients and providers. The Barclay Damon team has successfully represented pharmacies that have had their dispensing practices come under siege based on arbitrary and unilateral restrictions imposed by PBMs that are unrelated to patient care.

If you have any questions regarding the content of this blog post, please contact Linda Clark, health care controversies team leader, at lclark@barclaydamon.com; Brad Gallagher, counsel, at bgallagher@barclaydamon.com; Brenda Baddam, associate, at bbaddam@barclaydamon.com; or another member of the firm’s health care controversies team.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Subscribe

Sign up to receive our latest news via email

Practice Areas

Featured Industries

New & Emerging Industry Practice Areas

Other

View our Privacy Policy

Featured Media

Alerts

COVID-19: Updated Guidance Issued on NYS Construction Industry Workforce Reduction Requirements

Alerts

COVID-19: President Trump Signs $2.2 Trillion Economic Stimulus Package

Alerts

COVID-19: US Economic Stimulus Bill Includes Employee Retention Credit for Employers

Alerts

COVID-19: USDOL Issues Updated Guidance on Compliance With Families First Coronavirus Response Act

Alerts

COVID-19: US EPA Issues Policy to Regulated Entities

Alerts

COVID-19: DOJ and Other Regulators Warn of Hoarding, Price Gouging Amid Crisis

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out